About Larimar Therapeutics Inc.

Website
Website
Employees
Employees
11-50 employees View all
Industry
Industry
Biotechnology
Location
Location
Suite 506,Bala Cynwyd,PA,US
Description
Information
Larimar Therapeutics, Inc. (Nasdaq:LRMR), is a clinical-stage biotechnology company focused on developing treatments for complex rare diseases. The company’s lead compound, CTI-1601, is currently being evaluated in a Phase 1 clinical program as a potential treatment for Friedreich’s ataxia, a rare and progressive genetic disease. Larimar also plans to use its intracellular delivery platform to design other fusion proteins to target additional rare diseases characterized by deficiencies in intracellular bioactive compounds. For more information, please visit: https://larimartx.com.

Larimar Therapeutics Inc. Alternatives

Industry
biotechnology
Industry
Biotechnology
Industry
Biotechnology
Industry
biotechnology

Frequently Asked Questions about Larimar Therapeutics Inc.

What is Larimar Therapeutics Inc. email format?

The widely used Larimar Therapeutics Inc. email format is {f}{last} (e.g. [email protected]) with 75.00% adoption across the company.


What is Larimar Therapeutics Inc. customer service number?

To contact Larimar Therapeutics Inc. customer service number in your country click here to find.


Supercharge your
Prospecting &
Outreach with
ContactOut
Supercharge your Prospecting &
Outreach with ContactOut

Search Portal

Find countless prospects outside of LinkedIn fast

Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.

Discover the source of our data

Learn more